Clinical Takeaway

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

0.5 EA, 0.5 RP

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

0.5 EA, 0.5 RP

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

0.5 EA, 0.5 RP

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

0.5 EA, 0.5 RP

The reality of epigenetic tests in general practice may not be that far away

0.5 EA, 0.5 RP

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

Expert/s: Dr Gary Deed
0.5 EA, 0.5 RP

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

0.5 EA, 0.5 RP

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

0.5 EA, 0.5 RP

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

0.5 EA, 0.5 RP

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

0.5 EA, 0.5 RP

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

0.5 EA, 0.5 RP

GLP1 agonists are a very important management option - GPs who have not yet used this class of medications should learn more and start

1 EA, 0.5 RP

Acute vestibular and acute transient vestibular syndromes and confirming the diagnosis of vestibular neuritis

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

The reality of epigenetic tests in general practice may not be that far away

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

Expert/s: Dr Gary Deed

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

GLP1 agonists are a very important management option - GPs who have not yet used this class of medications should learn more and start

Acute vestibular and acute transient vestibular syndromes and confirming the diagnosis of vestibular neuritis